Form 4 for TMO Thermo Fisher Scientific
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001127602-22-006853 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-25 | 2022-02-23 | TMO | Boxer Michael A | SVP, Gen. Counsel, Sec | F - Tax | $528.58 | -419 | 12.8K | -3% | -$221.5K |
| DM | 2022-02-25 | 2022-02-23 | TMO | Boxer Michael A | SVP, Gen. Counsel, Sec | A - Grant | $0.00 | +2,266 | 13.0K | +21% | $0 |
| D | 2022-02-25 | 2022-02-23 | TMO | Boxer Michael A | SVP, Gen. Counsel, Sec | A - Grant | $0.00 | +3,984 | 3,984 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | F | D | 172 | $528.58 | 12,496 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-23 | F | D | 247 | $528.58 | 12,765 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-23 | A | A | 1,750 | $0.00 | 12,668 | D | — | — | (F1) Shares represent a performance-based restricted stock unit award granted on February 23, 2021. The Company's Compensation Committee determined on February 23, 2022, that the performance criteria related to this award were satisfied. One-third of the shares vested on February 23, 2022, and one-third of the shares vest on February 23, 2023. The remaining one-third will vest on February 23, 2024, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2021, through to December 31, 2023. |
| 4 | Common | Common Stock | 2022-02-23 | A | A | 516 | $0.00 | 13,012 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-02-23 | A | A | 3,984 | $0.00 | 3,984 | D | $528.58 · — to 2030-02-23 | 3,984 Common Stock | (F2) The option vests in four equal annual installments beginning on February 28, 2023. |